Buprenorphine transdermal patch
BUP12-AP-401
Approved small_molecule completed
Quick answer
Buprenorphine transdermal patch for Osteoarthritis is a Approved program (small_molecule) at Mundipharma Pty Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mundipharma Pty Limited
- Indication
- Osteoarthritis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed